Australia · Delayed Price · Currency is AUD · Option4DMedical Company Description
4DMedical Limited operates as a medical technology company in the United States and Australia.
The company engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging.
It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner.
The company was incorporated in 2012 and is based in Carlton, Australia.
| Country | Australia |
| Founded | 2012 |
| Industry | Prepackaged Software |
| Employees | 124 |
| CEO | Andreas Fouras |
Contact Details
Address: Melbourne Connect Carlton, 3053 Australia | |
| Phone | 61 3 9545 5940 |
| Website | 4dmedical.com |
Stock Details
| Ticker Symbol | 4DXOB |
| Exchange | Australian Securities Exchange |
| Stock Type | Option |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Andreas Fouras | Chief Executive Officer |
| Chris Cox | Chief Financial Officer |